Post by
turner20001 on Jan 06, 2024 9:39pm
APDN Having Serious Cash Problems!!! (See Latest SEC Filing)
"On January 4, 2024, in connection with certain cost management efforts, Applied DNA Sciences, Inc. (the "Company”) entered into letter agreements with the Company’s President and Chief Executive Officer, James A. Hayward, Ph.D., Sc.D. (the "Hayward Letter Agreement”), and the Company’s Chief Operating Officer, Judith Murrah (the "Murrah Letter Agreement”). The Hayward Letter Agreement amends Dr. Hayward’s employment agreement with the Company and provides for a temporary 45% reduction to Dr. Hayward’s annual base salary, from $450,000 to $250,000, for a period of three months, effective as of January 1, 2024 through March 31, 2024. Dr. Hayward also agreed to waive any right to resign for "good reason” under his employment agreement with the Company as a result of the foregoing salary reduction. The Murrah Letter Agreement provides for a temporary 25% reduction to Ms. Murrah’s annual base salary, from $325,000 to $243,750, for a period of three months, effective as of January 1, 2024 through March 31, 2024."